Monograph Details
|
|
Ob/Gyn
> Contraception
|
|
NORA-BE |
| Manufacturer |
|
Watson Pharmaceuticals, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Progestin. |
| Generic Name |
|
Norethindrone 0.35mg (28 tabs). |
| Indications |
|
Oral contraception. |
| Children |
Not applicable.
|
| Adults |
|
Continuous regimen: 1 tab daily. |
| Contraindications |
|
Breast carcinoma. Undiagnosed abnormal genital bleeding. Liver tumors. Pregnancy (Cat.X). |
| Precautions |
|
Cigarette smoking. Do physical exams at least annually. Discontinue if migraine or other serious headaches occur. Use back-up contraception for 48 hours if taken 3 hours or more late. Nursing mothers: if not exclusively breastfeeding may start 3 weeks after delivery; if fully breastfeeding may start 6 weeks after delivery. |
| Interactions |
|
Antagonized by hepatic enzyme-inducing drugs (eg, phenobarbital, rifampin). |
| Adverse Reactions |
|
Menstrual irregularities, frequent or irregular bleeding, mastodynia, headache, nausea, dizziness; androgenic effects (rare). |
| How Supplied |
|
Packs—6 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
